The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $392,590 in first-year total cost, median $196,295.
Most frequent study sections
- Arthritis and Musculoskeletal and Skin Diseases Clinical Trials Study Section [AMSC]2
Most frequent institutions
- MASSACHUSETTS GENERAL HOSPITAL1
- STANFORD UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Get moving, GET living: Graded exposure treatment for adolescents with chronic musculoskeletal pain.1R21AR072921-01A1 | SIMONS, LAURA E | STANFORD UNIVERSITY, CA | $207,240 | AMSC |
| 2018 | Optimizing Calcitriol Monotherapy for X-Linked Hypophosphatemia: Effects on Mineral Ions, Growth and Skeletal Parameters1R21AR072351-01A1 | DEMAY, MARIE | MASSACHUSETTS GENERAL HOSPITAL, MA | $185,350 | AMSC |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.